Functional uncoupling of endothelial nitric oxide synthase (i.e. enzymatic production of superoxide, O2− instead of nitric oxide) may also contribute to decreased NO bioavailability [70], and such effects can be observed in an animal model of obesity without high blood pressure or hyperglycemia [71,72]. This evidence concerns the gene NOS3 and Hyperglycemia.